EyePoint Pharmaceuticals
EYPT
EYPT
52 hedge funds and large institutions have $46.2M invested in EyePoint Pharmaceuticals in 2020 Q2 according to their latest regulatory filings, with 6 funds opening new positions, 15 increasing their positions, 17 reducing their positions, and 20 closing their positions.
New
Increased
Maintained
Reduced
Closed
more funds holding in top 10
Funds holding in top 10: →
less ownership
Funds ownership: →
less repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
less funds holding
Funds holding: →
30% less call options, than puts
Call options by funds: $21K | Put options by funds: $30K
33% less capital invested
Capital invested by funds: $69M → $46.2M (-$22.8M)
70% less first-time investments, than exits
New positions opened: 6 | Existing positions closed: 20
Holders
52
Holding in Top 10
1
Calls
$21K
Puts
$30K
Top Buyers
| 1 | +$331K | |
| 2 | +$204K | |
| 3 | +$155K | |
| 4 |
PP
Paloma Partners
Greenwich,
Connecticut
|
+$110K |
| 5 |
Bank of America
Charlotte,
North Carolina
|
+$84.2K |
Top Sellers
| 1 | -$2.08M | |
| 2 | -$830K | |
| 3 | -$650K | |
| 4 |
Northern Trust
Chicago,
Illinois
|
-$494K |
| 5 |
IAN
Integrated Advisors Network
Dallas,
Texas
|
-$488K |